Actively Recruiting

Phase Not Applicable
All Genders
ID07104955

Impact of Salutare One Referral Software on Effectiveness and Safety of Multi-Disciplinary Team Meetings in Patient Care

Led by Salutare Group Ltd. · Updated on 2025-08-05

40

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the Salutare One Referral software designed to improve Multi-Disciplinary Team (MDT) meetings, which are essential for planning patient care in the National Health Service (NHS). The study addresses challenges like time-consuming meetings, incomplete patient information, and repeated case discussions that can delay treatment decisions and affect care quality. This study aims to test whether the software can make MDT meetings more efficient and improve patient care coordination. The study follows a "before and after" design with multiple phases. Initially, MDT meetings occur without the software to collect baseline data. Then, participants receive training and use the One Referral software during MDT meetings, followed by observations and surveys to evaluate its impact. Finally, the study observes MDT meetings again without the software to compare outcomes. This approach helps assess the software's safety, feasibility, and acceptability. Participants involved in the study include MDT panel members, coordinators, and staff who submit referrals. They will complete surveys and be observed during MDT meetings at various stages. The study collects pseudonymized patient data to evaluate changes in MDT review effectiveness. Key outcomes include measuring the software's safety, implementation feasibility, and acceptability over periods of 4 to 8 weeks, depending on the MDT meeting type, to understand its potential to enhance patient care across the NHS.

CONDITIONS

Brief Title

Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • MDT meeting panel members, coordinators, or staff who submit MDT referrals
Not Eligible

You will not qualify if you...

  • MDT meeting panel members, coordinators, or staff who are unwilling or unable to take part in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit

Pre-intervention Phase

Duration - Duration not specified

Participants engage in the standard multi-disciplinary team (MDT) process without the One Referral software. Baseline MDT meeting observation data is collected, and participants complete a baseline survey.

MDT meetings as per usual schedule

Onboarding Phase

Duration - Duration not specified

Participants receive training on how to use the One Referral software and complete an onboarding survey.

1 training session and survey completion

Intervention Phase

Duration - 4 to 8 weeks depending on MDT type

Participants use the One Referral software as part of the MDT referral and review process. MDT meeting observation data is collected and participants complete an intervention survey.

4 to 8 MDT meetings (depending on MDT complexity and volume)

Post-intervention Phase

Duration - Duration not specified

Participants return to the standard MDT process without the One Referral software. Follow-up MDT meeting observation data is collected and participants complete an offboarding survey.

MDT meetings as per usual schedule

Trial Site Locations

Total: 1 location

1

Royal National Orthopaedic Hospital

London, United Kingdom, HA7 4LP

Actively Recruiting

Loading map...

Research Team

L

Liba Stones, MA, MBA

C

Chris Dial

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here